Clinical Trial Update: Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and efficacy results for oral PF-4136309 in patients with chronic hepatitis C and abnormal liver enzymes; study terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PF-4136309

Snippet

Sponsor: Pfizer | Conditions: Hepatitis C, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2023-07-27